Catalyst Wire Dossier Catalyst Wire Dossier

REMAXA

· POLYSAN Scientific & Technological Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REMAXA, covering 2025-04-29 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis [Phase 2, Phase 3]

See pricing